Every day, in thousands of hospitals, skilled nursing facilities, and pharmacies across the United States, healthcare workers crush medications as part of routine care. For patients who cannot swallow solid oral dosage forms, crushing is a necessary clinical step.
But when the medication being crushed is classified as a hazardous drug — and more drugs qualify than most facilities realize — that routine act becomes a regulated exposure event under USP General Chapter <800>.
Links Medical Products (LMP) is committed to delivering innovative, high-quality healthcare solutions that improve patient outcomes and support caregivers across the markets we serve. With a focus on clinical performance, reliability, and safety, our portfolio is designed to meet the evolving needs of post-acute care, pharmacy, hospice, EMS, and veterinary providers. Under the leadership of Patrick Buckley, President & CEO, LMP continues to expand its offerings and reinforce its reputation as a trusted partner in healthcare.
This post is related to:
